Evidence map›Paper›PMID 37370323›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Fabrication and Characterisation of the Cytotoxic and Antibacterial Properties of Chitosan-Cerium Oxide Porous Scaffolds.

Lemiha Yildizbakan, Neelam Iqbal, Payal Ganguly, Eric Kumi-Barimah, Thuy Do, Elena Jones, Peter V Giannoudis, Animesh Jha

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lemiha YildizbakanSchool of Chemical and Process Engineering, University of Leeds, Leeds LS2 9JT, UK.ORCID 0000-0002-1914-5205
Neelam IqbalSchool of Chemical and Process Engineering, University of Leeds, Leeds LS2 9JT, UK.ORCID 0000-0002-2801-707X
Payal GangulyLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds LS9 7JT, UK.ORCID 0000-0003-1042-5910
Eric Kumi-BarimahSchool of Chemical and Process Engineering, University of Leeds, Leeds LS2 9JT, UK.ORCID 0000-0003-4841-9866
Thuy DoDivision of Oral Biology, School of Dentistry, University of Leeds, Leeds LS9 7TF, UK.ORCID 0000-0002-5668-2181
Elena JonesLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds LS9 7JT, UK.ORCID 0000-0001-9365-2283
Peter V GiannoudisAcademic Department of Trauma and Orthopaedic Surgery, School of Medicine, University of Leeds, Leeds LS2 9JT, UK.ORCID 0000-0002-5205-7696
Animesh JhaSchool of Chemical and Process Engineering, University of Leeds, Leeds LS2 9JT, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone damage arising from fractures or trauma frequently results in infection, impeding the healing process and leading to complications. To overcome this challenge, we engineered highly porous chitosan scaffolds (S1, S2, and S3) by incorporating 30 (wt)% iron-doped dicalcium phosphate dihydrate (Fe-DCPD) minerals and different concentrations of cerium oxide nanoparticles (CeO

Indexed as

antibacterial scaffoldcerium oxidechitosancytotoxicitytissue engineering

Identifiers

PMID37370323
PMCPMC10295205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.